Elisabeth J. M. Huijbers

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy

Judy R. van Beijnum, Elisabeth J. M. Huijbers, Karlijn van Loon et al. · Nature Communications · 2022 · 84 citations · Full text

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity

Yvette W.J. Paulis, Elisabeth J. M. Huijbers, Daisy W.J. van der Schaft et al. · Oncotarget · 2015 · 73 citations · Full text

Tumor Biology, Aggressive Tumor Cells, Cd44 Expression +10

Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer

Julia Femel, Elisabeth J. M. Huijbers, Falk Saupe et al. · Oncotarget · 2014 · 60 citations · Full text

Vaccination against the extra domain‐B of fibronectin as a novel tumor therapy

Elisabeth J. M. Huijbers, Maria Ringvall, Julia Femel et al. · The FASEB Journal · 2010 · 50 citations

Immunology, Pathology, Immune System +19

Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy

Patrycja Nowak‐Sliwinska, Judy R. van Beijnum, Christian J. Griffioen et al. · Angiogenesis · 2022 · 46 citations · Full text